Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London · Delayed Price · Currency is GBP · Price in USD 360.23
-8.68 (-2.35%)
Jan 14, 2026, 6:48 PM GMT
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 36.04 billion as of January 14, 2026. Its market cap has increased by 44.22% in one year.
Market Cap
36.04B
Enterprise Value
36.07B
Revenue
2.39B
Ranking
n/a
PE Ratio
1,111.87
Stock Price
360.23
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 36.04B, an increase of 56,894.83%. That is a compound annual growth rate of 34.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 36.39B | -6.76% |
| Dec 31, 2025 | 39.03B | 61.01% |
| Dec 31, 2024 | 24.24B | 28.56% |
| Dec 29, 2023 | 18.86B | -22.29% |
| Dec 30, 2022 | 24.27B | 62.00% |
| Dec 31, 2021 | 14.98B | 35.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.25B |
| GSK plc | 74.55B |
| Haleon | 32.28B |
| Smith & Nephew | 10.22B |
| Convatec Group | 4.60B |
| Hikma Pharmaceuticals | 3.41B |
| HUTCHMED (China) | 1.90B |
| Genus | 1.68B |